Metformin reverses nicotine-induced gefitinib resistance by epithelial-mesenchymal transition
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the molecular basis for nicotine(NIC) to induce resistance of epithelial growth factor receptor tyrosine kinase inhibitors(EGFR-TKI) in EGFR-mutated PC-9 cells and the effect of the metformin in the process. Methods:PC-9 cells were divided into 4 groups,namely control group,NIC group,MET group and MET+NIC group. EMT markers were detected by quantificational real-time polymerase chain reaction(qRT-PCR) and Western blot. Cell counting Kit-8(CCK-8) assays were used to evaluate the sensibility to gefitinib of different group cells. The invasion ability and migration ability of different groups were detected by Transwell assay. Results:Nicotine in-duced epithelial-mesenchymal transition(EMT) of PC-9 cells in a time and concentration dependent manner. Down-regulation of E-cadherin and up-regulation of Vimentin were most significant with a treatment of 10 μmol/L nicotine for 10 h,so further experi-ments were completed under this condition. CCK-8 displayed reduction of gefitinib sensitivity of PC-9 cells in the NIC group com-pared with the control group,especially with a gefitinib concentration of 0.05 μmol/L(F=82.005,P=0.000,P=0.000). In invasion as-says,more penetrating cells were observed in the NIC group than in the control group[(15.70±1.53) vs. (32.70±2.08),F=75.406,P=0.000,P=0.000]. Migration assays presented similar results [(102.70±7.02) vs. (18.70±2.08),F=204.038,P=0.000,P=0.000]. E-cadherin mRNA expression decreased[(0.932±0.100) vs. (0.459±0.024),F=25.924,P=0.000,P=0.000] and Vimentin mRNA expression increased[(1.200±0.200) vs. (1.973±0.129),F=20.998,P=0.000,P=0.000] in the NIC group compared with the control group,and Western blot showed the same results. Cells in the MET+NIC group displayed higher sensitivity to gifitinib,which is statis-tically significant with a gifitinib concentration of 0.05,0.10,0.50,1.00 and 5.00 μmol/L. Fewer cells penetrated the Matrigel in the NIC+MET group[(17.00±2.00) vs. (32.70±2.08),F=75.406,P=0.000,P=0.000] and migration assays presented similar results [(51.70±5.03) vs. (102.70±7.02),F=204.038,P=0.000,P=0.000]. E-cadherin mRNA expression was upregulated[(0.459±0.024) vs. (0.838±0.058),F=25.924,P=0.000,P=0.000],and Vimentin mRNA expression was downregulated [(1.973±0.129) vs. (1.467±0.115),F=20.998,P=0.000,P=0.003] in the NIC+MET group compared with the NIC group. Western blot showed the same results. Conclusion:Nicotine induced EGFR-TKI resistance in PC-9 cells by EMT in non-small cell lung cancer,which could be reversed by metformin.

    Reference
    Related
    Cited by
Get Citation

Hu Jing, Li Jun, Li Dandan, Zhang Lu, Zhang Hui, Chen Hong. Metformin reverses nicotine-induced gefitinib resistance by epithelial-mesenchymal transition[J]. Journal of Chongqing Medical University,2019,(3):260-

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: April 30,2019
  • Published:
Article QR Code